ANTI-CARBAMYLATED PROTEIN ANTIBODIES ARE ASSOCIATED WITH LONG TERM DISABILITY AND DISEASE ACTIVITY IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM THE NORFOLK ARTHRITIS REGISTER

Abstract

Pathophysiology and treatment of rheumatic disease